Canada markets close in 5 hours 44 minutes

ARCA biopharma, Inc. (ABIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2400-0.0100 (-0.44%)
As of 10:14AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 32.42M
Enterprise Value -25.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.57
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.36

Trading Information

Stock Price History

Beta (5Y Monthly) 2.51
52-Week Change 3-44.99%
S&P500 52-Week Change 322.93%
52 Week High 35.5000
52 Week Low 32.1700
50-Day Moving Average 32.6292
200-Day Moving Average 33.2438

Share Statistics

Avg Vol (3 month) 3412.71k
Avg Vol (10 day) 3495.39k
Shares Outstanding 514.41M
Implied Shares Outstanding 6N/A
Float 814.3M
% Held by Insiders 10.74%
% Held by Institutions 110.61%
Shares Short (Nov. 14, 2021) 4450.71k
Short Ratio (Nov. 14, 2021) 40.57
Short % of Float (Nov. 14, 2021) 43.13%
Short % of Shares Outstanding (Nov. 14, 2021) 43.13%
Shares Short (prior month Oct. 14, 2021) 4297.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr. 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:18
Last Split Date 3Apr. 03, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.93%
Return on Equity (ttm)-35.07%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -18.77M
Net Income Avi to Common (ttm)-18.77M
Diluted EPS (ttm)-1.4850
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)58.31M
Total Cash Per Share (mrq)4.05
Total Debt (mrq)507k
Total Debt/Equity (mrq)0.90
Current Ratio (mrq)18.75
Book Value Per Share (mrq)3.93

Cash Flow Statement

Operating Cash Flow (ttm)-16.81M
Levered Free Cash Flow (ttm)-10.27M